News Releases

Explore all the latest news from Johnson & Johnson Vision around the globe.*

JOHNSON & JOHNSON VISION APPOINTS PETER MENZIUSO AS COMPANY GROUP CHAIRMAN
JOHNSON & JOHNSON VISION APPOINTS PETER MENZIUSO AS COMPANY GROUP CHAIRMAN

Menziuso brings 30 years of deep healthcare expertise, with a focus on redefining healthy sight

JACKSONVILLE, Fla. AND SANTA ANA, Calif. – May 3, 2022 – Johnson…

JOHNSON & JOHNSON VISION APPOINTS PETER MENZIUSO AS COMPANY GROUP CHAIRMAN
Abiliti
JOHNSON & JOHNSON VISION LAUNCHES ACUVUE® ABILITI™ BRAND IN HONG KONG TO ADDRESS GROWING PREVALENCE OF MYOPIA
With an incidence rate of 88%, Hong Kong is among cities with the highest prevalence of myopia in the world1, and children are particularly vulnerable as myopia affects approximately 61.5% of…
JOHNSON & JOHNSON VISION LAUNCHES ACUVUE® ABILITI™ BRAND IN HONG KONG TO ADDRESS GROWING PREVALENCE OF MYOPIA
TearScience
Johnson & Johnson Vision Introduces Next-Generation TearScience Activator Clear to Offer Eye Care Professionals and Patients Unparalleled Consistency and Precision in the Treatment of Meibomian Gland Dysfunction (MGD)

New activator for the TearScience LipiFlow Thermal Pulsation System was developed with efficacy and the environment in mind

SANTA ANA, CALIF. – April 22, 2022 – Johnson & Johnson…

Johnson & Johnson Vision Introduces Next-Generation TearScience Activator Clear to Offer Eye Care Professionals and Patients Unparalleled Consistency and Precision in the Treatment of Meibomian Gland Dysfunction (MGD)

Feature Stories

Johnson & Johnson Media Center

For more information about the latest Johnson & Johnson
news and publications visit the Media Center at www.jnj.com

Johnson & Johnson Media Center

Social Media LIVE

 

*Johnson & Johnson Vision medical device information contained in the News Releases are specific to the market highlighted and is not intended for dissemination outside the intended market.

PP2023OTH5448